135 related articles for article (PubMed ID: 8194892)
1. Differentiation markers for lung-cancer sub-types. A comparative study of their expression in vivo and in vitro.
Broers JL; Ramaekers FC
Int J Cancer Suppl; 1994; 8():134-7. PubMed ID: 8194892
[TBL] [Abstract][Full Text] [Related]
2. Reactivity of lung tumors with lung-derived and non-lung-derived monoclonal antibodies.
Ioachim HL; Pambuccian S; Giancotti F; Dorsett B
Int J Cancer Suppl; 1994; 8():132-3. PubMed ID: 7515026
[TBL] [Abstract][Full Text] [Related]
3. Coexpression of ganglioside antigen Fuc-GM1, neural-cell adhesion molecule, carcinoembryonic antigen, and carbohydrate tumor-associated antigen CA 50 in lung cancer.
Brezicka FT; Olling S; Bergman B; Berggren H; Engström CP; Hammarström S; Holmgren J; Larsson S; Lindholm L
Tumour Biol; 1992; 13(5-6):308-15. PubMed ID: 1337798
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas.
Linnoila RI; Mulshine JL; Steinberg SM; Funa K; Matthews MJ; Cotelingam JD; Gazdar AF
Am J Clin Pathol; 1988 Dec; 90(6):641-52. PubMed ID: 2848408
[TBL] [Abstract][Full Text] [Related]
5. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K
Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917
[TBL] [Abstract][Full Text] [Related]
6. In vitro invasion of small-cell lung cancer cell lines correlates with expression of epidermal growth factor receptor.
Damstrup L; Rude Voldborg B; Spang-Thomsen M; Brünner N; Skovgaard Poulsen H
Br J Cancer; 1998 Sep; 78(5):631-40. PubMed ID: 9744504
[TBL] [Abstract][Full Text] [Related]
7. Expression of neuroendocrine and epithelial markers in an adherent subline derived from a classic small cell lung cancer cell line.
Walker C; Wright-Perkins S
Oncol Res; 1992; 4(10):419-29. PubMed ID: 1337994
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of neuroendocrine differentiation in lung cancer cell lines featured by cytomorphology, markers, and their corresponding tumors.
Linnoila RI
J Cell Biochem Suppl; 1996; 24():92-106. PubMed ID: 8806093
[TBL] [Abstract][Full Text] [Related]
9. An adherent subline of a unique small-cell lung cancer cell line downregulates antigens of the neural cell adhesion molecule.
Doyle LA; Borges M; Hussain A; Elias A; Tomiyasu T
J Clin Invest; 1990 Dec; 86(6):1848-54. PubMed ID: 1701450
[TBL] [Abstract][Full Text] [Related]
10. Expression of cadherin and NCAM in human small cell lung cancer cell lines and xenografts.
Rygaard K; Møller C; Bock E; Spang-Thomsen M
Br J Cancer; 1992 Apr; 65(4):573-7. PubMed ID: 1314069
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody SEN7 recognizes a new epitope on the neural cell adhesion molecule present on small cell lung cancer but not on lymphocytes.
Waibel R; Mannhart M; O'Hara CJ; Brocklehurst C; Zangemeister-Wittke U; Schenker T; Lehmann HP; Weber E; Stahel RA
Cancer Res; 1993 Jun; 53(12):2840-5. PubMed ID: 7684948
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of serum neural cell adhesion molecule as a new tumor marker in small cell lung cancer.
Jaques G; Auerbach B; Pritsch M; Wolf M; Madry N; Havemann K
Cancer; 1993 Jul; 72(2):418-25. PubMed ID: 8391379
[TBL] [Abstract][Full Text] [Related]
13. [Value of combined detection of tumor markers for the prediction of small cell and non-small cell lung cancer].
Wu Y; Wu Y; Wang L; Qu L
Wei Sheng Yan Jiu; 2000 Jul; 29(4):213-5. PubMed ID: 12520921
[TBL] [Abstract][Full Text] [Related]
14. NCAM: a surface marker for human small cell lung cancer cells.
Aletsee-Ufrecht MC; Langley K; Rotsch M; Havemann K; Gratzl M
FEBS Lett; 1990 Jul; 267(2):295-300. PubMed ID: 2165922
[TBL] [Abstract][Full Text] [Related]
15. Preferential histiotypic expression of CD44-isoforms in human lung cancer.
Wimmel A; Schilli M; Kaiser U; Havemann K; Ramaswamy A; Branscheid D; Kogan E; Schuermann M
Lung Cancer; 1997 Mar; 16(2-3):151-72. PubMed ID: 9152947
[TBL] [Abstract][Full Text] [Related]
16. Integrated classification of lung tumors and cell lines by expression profiling.
Virtanen C; Ishikawa Y; Honjoh D; Kimura M; Shimane M; Miyoshi T; Nomura H; Jones MH
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12357-62. PubMed ID: 12218176
[TBL] [Abstract][Full Text] [Related]
17. Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features.
Berendsen HH; de Leij L; Poppema S; Postmus PE; Boes A; Sluiter HJ; The H
J Clin Oncol; 1989 Nov; 7(11):1614-20. PubMed ID: 2553880
[TBL] [Abstract][Full Text] [Related]
18. Immunocytologic diagnosis of small-cell lung cancer in imprint smears.
Tome Y; Hirohashi S; Noguchi M; Matsuno Y; Kishi K; Uei Y; Shimosato Y
Acta Cytol; 1991; 35(5):485-90. PubMed ID: 1656682
[TBL] [Abstract][Full Text] [Related]
19. Impact of neuroendocrine differentiation in non-small cell lung cancer. The LCSG experience.
Linnoila RI; Piantadosi S; Ruckdeschel JC
Chest; 1994 Dec; 106(6 Suppl):367S-371S. PubMed ID: 7988266
[TBL] [Abstract][Full Text] [Related]
20. Neural cell adhesion molecule expression and messenger RNA splicing patterns in lung cancer cell lines are correlated with neuroendocrine phenotype and growth morphology.
Carbone DP; Koros AM; Linnoila RI; Jewett P; Gazdar AF
Cancer Res; 1991 Nov; 51(22):6142-9. PubMed ID: 1718595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
